Participated · Series E · Jul 2024

Spring Health provides Precision Mental Healthcare for employers and health plans, connecting individuals and families with personalized, culturally-responsive mental health interventions and support. The platform is certified by the Validation Institute for demonstrating net savings and delivering net-positive financial return for organizations. More than 10 million people worldwide have access to Spring Health through employers, health plans and channel partners, including Adobe, Bumble, Delta, General Mills, Highmark Health and Guardian. Led by co-founder and CEO April Koh, the company uses clinical expertise, technology and insights to support employee mental health and well-being. Spring Health recently raised $100M in a Series E at a $3.3B valuation and plans to use the funds to expand operations and broaden its business reach. The company emphasizes culturally-responsive care and measurable financial impact for customers. Spring Health provides employers with a comprehensive mental-health benefits platform that uses a proprietary assessment and machine-learning technology to identify conditions and match members to personalized care plans. Each member has access to a Care Navigator who assists with booking appointments and connecting employees to domain experts across work-life, legal, and financial services. The company emphasizes matching members to the right care rather than one-size-fits-all offerings. It plans to use new capital to expand adoption among employers and grow partnerships with health plans. In September 2021 Spring Health raised $190 million in a Series C at a $2.0 billion valuation, and the new investment brought total capital raised to $300 million. Spring Health was founded in 2016 and is based in New York, US. Spring Health provides employers with a comprehensive behavioral health benefits solution that offers access to digital exercises, EAP services, coaching, therapy, and medication. The company combines a proprietary mix of technology with human care, an approach founded in science and academia. Led by co-founder and CEO April Koh, Spring Health aims to deliver highly personalized mental-health experiences. The company is using new funding to expand its capabilities and scale its team. Spring Health intends to triple its New York-based team to support growth and product development. Financially, the company has raised $106M to date, including the recent Series B. Spring Health is a New York-based digital wellness platform operating an online mental health clinic. Led by CEO and co-founder April Koh, the company uses proprietary clinically-validated AI to generate personalized wellness recommendations, including treatment options, exercise regimens, and self-help resources. Users register and complete a dynamic questionnaire that adapts to responses; the AI recommends plans based on aggregated clinical trials and thousands of electronic health records. Patients are matched with personal care navigators (trained clinicians) and licensed mental health professionals from Spring Health’s provider network using proprietary matching algorithms. Clients range from global Fortune 500 companies to high-growth startups such as DigitalOcean, Zola, and Niantic. The company plans to use the $6M seed funding to expand its product and scale to offer wellness benefits nationwide. Spring Health offers a tablet-based behavioral health screening and clinical decision support platform that uses a 25-question patient questionnaire and a machine-learning algorithm to recommend the most suitable depression drug when medication is necessary. The product is aimed at primary care physicians, who prescribe roughly 79% of antidepressants and often have limited comfort with behavioral-health treatment options. Spring Health positions its tool to reduce medication trial-and-error, lower costs, and ease clinician burden. The company has customers in New York and California and sees interest tied to New York’s Delivery System Reform Incentive Payment system. April Koh, the company’s CEO, has described the platform as part screening tool and part clinical decision support for PCP workflows.

Led · Series A · Aug 2023

KetoSwiss develops products aimed at improving brain energetics, a common denominator in many neurological and psychiatric diseases. Its first flagship medical food for migraine, MigraKet by Brain Ritual, pairs ketone bodies with micronutrients essential for brain energy metabolism. MigraKet is clinically tested, patent-protected, and is planned to enter the U.S. market at the end of 2023. The company is led by CEO and Founder Dr. Elena Gross and is based in Basel, Switzerland. KetoSwiss raised $4.8M in the second closing of a Pre-Series A financing and will use the funds to expand R&D and clinical development efforts.

Participated · Series A · Dec 2017

iRecommend Software develops a recommendation engine that leverages artificial intelligence, deep learning, and a proprietary algorithm to ingest big data from thousands of data feeds. The engine generates relevant, user-specific recommendations across retail, recruiting, real estate, entertainment, and healthcare industries. The company was founded in 2016 by John Morad and Mark Allen and is based in Tulsa, Okla. It plans to use the recent funding to expand global sales and marketing efforts and to complete a large online retail client integration. iRecommend also intends to commercialize SaaS subscription modules for the real estate and recruiting industries. The article reports the company closed a $1.85M Series A in December 2017.